Jiang Rui, Li Li, Yan Yunfei, Li Hucai, Yu Ruizhi, Huang Yang, Wang Lixin
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Department of Nephrology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Front Med (Lausanne). 2025 May 21;12:1594990. doi: 10.3389/fmed.2025.1594990. eCollection 2025.
To investigate the clinicopathological features and prognostic factors of idiopathic membranous nephropathy (IMN) patients with renal arteriolosclerosis, providing evidence for individualized clinical management.
A retrospective analysis was conducted on 597 biopsy-confirmed IMN patients at Guangdong Provincial Hospital of Chinese Medicine from January 1, 2012, to December 31, 2022. Patients were stratified into two groups based on the presence of renal arteriolosclerosis. Clinical and pathological characteristics were compared between groups. Kaplan-Meier curves were used to assess cumulative renal remission rates, and Cox regression analysis was performed to identify risk factors for composite endpoint events in IMN patients with arteriolosclerosis.
In a cohort of 597 IMN patients (55.6% male), significant baseline differences were observed in Serum Sodium, triglycerides, membranous nephropathy (MN) stage, mesangial proliferation, interstitial fibrosis, and IgG deposition between the arteriolosclerosis and non-arteriolosclerosis groups ( < 0.05). Kaplan-Meier analysis demonstrated markedly lower renal survival in the arteriolosclerosis group (Log-rank χ = 8.296, = 0.004). Multivariate Cox regression identified age (HR = 1.022, 95% CI 1.003-1.042; = 0.022), serum creatinine (SCr) (HR = 1.010, 95% CI 1.002-1.018; = 0.017), IgM 3 + deposition (HR = 4.718, 95% CI 1.003-1.042; < 0.001), and interstitial fibrosis (HR > 1, < 0.05) as independent risk factors for composite endpoint events, Compared to their respective reference groups, C1q (3+) and tubular atrophy (≥50%) have a protective effect against adverse renal outcomes (HR < 1, < 0.05).
Renal arteriolosclerosis portends poorer prognosis in IMN, with distinct clinicopathological features and accelerated renal function decline. Age, elevated creatinine, intense immune complex deposition, and advanced tubular-interstitial damage represent critical risk markers, highlighting the need for early vascular assessment and histology-guided risk stratification in this population.
探讨合并肾小动脉硬化的特发性膜性肾病(IMN)患者的临床病理特征及预后因素,为个体化临床管理提供依据。
对2012年1月1日至2022年12月31日在广东省中医院经活检确诊的597例IMN患者进行回顾性分析。根据是否存在肾小动脉硬化将患者分为两组。比较两组的临床和病理特征。采用Kaplan-Meier曲线评估累积肾脏缓解率,并进行Cox回归分析以确定合并小动脉硬化的IMN患者复合终点事件的危险因素。
在597例IMN患者队列中(男性占55.6%),小动脉硬化组和无小动脉硬化组在血清钠、甘油三酯、膜性肾病(MN)分期、系膜增生、间质纤维化和IgG沉积方面存在显著的基线差异(P<0.05)。Kaplan-Meier分析显示小动脉硬化组的肾脏生存率明显较低(对数秩检验χ²=8.296,P=0.004)。多因素Cox回归分析确定年龄(HR=1.022,95%CI 1.003-1.042;P=0.022)、血清肌酐(SCr)(HR=1.010,95%CI 1.002-1.018;P=0.017)、IgM 3+沉积(HR=4.718,95%CI 1.003-1.042;P<0.001)和间质纤维化(HR>1,P<0.05)为复合终点事件的独立危险因素,与各自的参照组相比,C1q(3+)和肾小管萎缩(≥50%)对不良肾脏结局具有保护作用(HR<1,P<0.05)。
肾小动脉硬化预示着IMN患者预后较差,具有独特的临床病理特征且肾功能下降加速。年龄、肌酐升高、强烈的免疫复合物沉积和严重的肾小管间质损伤是关键的风险标志物,凸显了对该人群进行早期血管评估和组织学指导的风险分层的必要性。